Serratia marcescens-associated bacteremic urinary tract infection: a case report

Abstract

Serratia marcescens (S. marcescens)  is a Gram negative bacilli in the family Enterobactericea and is an important cause of health care-related infections and intensive care outbreaks. In this article, an 82-year-old female patient admitted to bed, who was a persistent urinary tract infection due to bacteremic urinary tract infection due to S. marcescens, was referred to the literature. In conclusion, it should be kept in mind that S. marcescens and other Gram-negative bacteria may cause bacteraemia-induced urinary tract infections especially in bedridden patients who have persistent urinary incontinence, and urine culture and blood cultures should be taken in these patients.

Keywords

• Serratia marcescens,bacteriemi,urinary tract infection

Serratia marcescens ilişkili bakteremik üriner sistem infeksiyonu: olgu sunumu

Abstract

Serratia marcescens (S. marcescens), Enterobactericea ailesinde yer alan Gram negatif basil olup, sağlık bakımı ile ilişkili infeksiyonlar ve yoğun bakımda salgınların önemli bir etkenidir. Bu yazıda yoğun bakımda yatarken S. marcescens’e bağlı olarak bakteremik üriner sistem infeksiyonu gelişen kalıcı idrar sondası olan yatağa bağımlı 82 yaşında bir kadın hasta sunularak literatür gözden geçirildi. Sonuç olarak, özellikle kalıcı idrar sondası olan yatalak hastalarda S. marcescens ve diğer Gram nagatif bakterilerin bakteriyemi ile seyreden üriner sistem infeksiyonlarına neden olabileceği akılda tutulmalı ve bu hastalarda idrar kültürü ile birlikte kan kültürleri de alınmalıdır. 

Keywords

• Serratia marcescens,bakteriyemi,üriner sistem infeksiyonu

References

1. 1. Ustaçelebi Ş. Temel ve Klinik Mikrobiyoloji, eds; Erdem B. Enterobacteriaceae, Bölüm: 11, 1.Baskı, Güneş Kitabevi Ltd Şti, Ankara, 1999, s: 471-515.
2. 2. Ania B J: Serratia. Copyright 2002, eMedicine.com, Inc, 2002.
3. 3. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Color Atlas and Textbook of Diagnostic Microbiology, Chapter 4, 5th edition, Philadelphia, Lippincott Company 1997; p: 171-252.
4. 4. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstreaminfections in United States hospitals: a three-year analysis. Clin Infect Dis1999; 29: 239-44.
5. 5. Hejazi A, Falkiner FR: Serratia marcescens. J Med Microbiol 1997; 46: 903-12.
6. 6. Royo P, del Valle O, Boquete T. Epidemiology of Serratia marcescens between 1987 and 1995 at Valld'Hebron Hospital. Enferm Infec Microbiol Clin 15: 519-27, 1997.
7. 7. Calderwood SB. Infections due to Serratia species. https://www.uptodate.com/.../infections-due-to-serratia-species.
8. 8. Serratia infeksiyonları Herra C, Falkiner FR. Serratia marcescens. http://www.antimicrobe. org/b26.asp.

9. 9. Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 2010; 51 (Suppl1): S81-8.
10. 10. Kawecki D, Kwiatkowski A, Sawicka-Grzelak A, et al. Urinary tract infections in the early posttransplant period after kidney transplantation: etiologic agents and their susceptibility. Transplant Proc 2011; 43: 2991-3.
11. 11. Al-Hasan MN, Eckel-Passow JE, and Baddour LM. Bacteremia complicating gram-negative urinary tract infections: A Population-Based Study. J Infect 2010; 60: 278–85.
12. 12. Bahagon Y, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis 2007; 26: 349–52.
13. 13. Ackermann RJ, Monroe PW. Bacteremic urinary tract infection in older people. J Am Geriatr Soc 1996; 44: 927-33.
14. 14. Artero A, Esparcia A, Eiros JM, Madrazo M, Alberola J, Nogueira JM. Effect of Bacteremia in elderly patients with urinary tract infection. Am J Med Sci 2016; 352: 267-71.
15. 15. Liu JW, Hsu YM, Huang YF. Independent prognostic factors for fatality in patients with urinary tract infection caused by Serratia marcescens. Infect Control Hosp Epidemiol 2004; 25: 80-2.
16. 16. Cai JC, Zhou HW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008; 52: 2014-8. 17. Yu VL, Rhame FS, Pesanti EL, Axline SG. Amikacin therapy. Use against infections caused by gentamicin-and tobramycin-resistant organisms. JAMA 1977; 238: 943-7.
17. 18. Craven PC, Jorgensen JH, Kaspar RL, Drutz DJ. Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy. Am J Med 1977; 62: 902-10.